Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APT-001 in adults with blepharitis
NCT07904767Phase 2Not yet recruiting
- Sponsor
- Aperta Biosciences
- Start
- Dec 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of APT-001 in blepharitis, sponsored by Aperta Biosciences. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
APT-001
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT07904767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904767.